Ahmad Akram, Patel Isha, Parimilakrishnan Sundararajan, Mohanta Guru Prasad, Chung HaeChung, Chang Jongwha
Department of Pharmacy Practice, Annamalai University, Annamalai Nagar, Tamil Nadu, India.
Department of Clinical, Social and Administrative Sciences, University of Michigan, Ann Arbor, MI, USA.
J Res Pharm Pract. 2013 Jan;2(1):3-9. doi: 10.4103/2279-042X.114081.
Phamacoeconomics can aid the policy makers and the healthcare providers in decision making in evaluating the affordability of and access to rational drug use. Efficiency is a key concept of pharmacoeconomics, and various strategies are suggested for buying the greatest amount of benefits for a given resource use. Phamacoeconomic evaluation techniques such as cost minimization analysis, cost effectiveness analysis, cost benefit analysis, and cost utilization analysis, which support identification and quantification of cost of drugs, are conducted in a similar way, but vary in measurement of value of health benefits and outcomes. This article provides a brief overview about pharmacoeconomics, its utility with respect to the Indian pharmaceutical industry, and the expanding insurance system in India. Pharmacoeconomic evidences can be utilized to support decisions on licensing, pricing, reimbursement, and maintenance of formulary procedure of pharmaceuticals. For the insurance companies to give better facility at minimum cost, India must develop the platform for pharmacoeconomics with a validating methodology and appropriate training. The role of clinical pharmacists including PharmD graduates are expected to be more beneficial than the conventional pharmacists, as they will be able to apply the principles of economics in daily basis practice in community and hospital pharmacy.
药物经济学可以帮助政策制定者和医疗服务提供者在评估合理用药的可承受性和可及性方面进行决策。效率是药物经济学的一个关键概念，人们提出了各种策略，以便在给定的资源使用情况下获得最大数量的益处。药物经济学评估技术，如成本最小化分析、成本效益分析、成本效益分析和成本利用分析，这些技术支持对药物成本的识别和量化，其开展方式类似，但在健康益处和结果的价值衡量方面有所不同。本文简要概述了药物经济学、其在印度制药行业的效用以及印度不断扩大的保险体系。药物经济学证据可用于支持药品许可、定价、报销以及药品处方集程序维护等方面的决策。为了让保险公司以最低成本提供更好的服务，印度必须开发具有验证方法和适当培训的药物经济学平台。包括药学博士毕业生在内的临床药师的作用预计将比传统药师更具益处，因为他们能够在社区和医院药房的日常实践中应用经济学原理。
